How a new "breathalyzer" from the College of Veterinary Medicine could change the future of canine heart health.
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012.
Mitral regurgitation is the most prevalent valvular heart disease in humans. It's also common among dogs, especially older and smaller breed dogs. In both species, the mitral valve fails to close ...
Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...
The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results